Clinical Trials in China / NCT06987760
Recruiting
Not applicable
Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones
NCT06987760 · tracked via the Priya Life Science China tracker
Condition(s) studied
Ureter InjuryUrolithiasis; Lower Urinary TractEfficacy, Self
Investigational drug(s) / intervention(s)
flexible ureteroscope urolithiasis
flexible ureteroscope urolithiasis: Using flexible ureteroscope combine with urethral access sheath to treatment urolithiasis
Study summary
Comparing the Efficiency, Effectiveness, and Safety of fURS lithotripsy with Similar RESDs in the Treatment of Upper Urinary Tract Stones.
Eligibility
Inclusion Criteria:
\- 1.Patients with kidney stones or upper ureteral stones with a cumulative diameter of less than 3 cm are selected for ureteral soft lens holmium laser lithotripsy.
2.Age 18 to 80 years old, gender unlimited. 3.The subjects have no mental illness or language dysfunction, can understand the situation of the study and can sign informed consent.
Exclusion Criteria:
* 1.Patients with a history of ureteral stenosis or who have undergone open or laparoscopic ureteral or renal lithotomy.
2.Patients with fever one week before surgery 3.Pregnant women and menstruating patients. 4.Patients with combined systemic disease or inability to tolerate anesthesia. 5.Patients undergoing simultaneous surgery for bilateral upper urinary tract stones.
6.Patients with ureteral stent indwelling before surgery. 7.In patients with severe hydronephrosis, the separation of the renal collecting system is greater than 4 cm.
8.Patients with renal anatomic malformations such as polycystic kidney, horseshoe kidney, and ectopic kidney.
Primary outcome measure(s)
- Success rate of ureteral access sheath insertion — From enrollment to completion of surgery
Proportion of successful ureteral implantation, success rate = number of successful cases/total number of cases
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| The First Affiliated Hospital of Ningbo University | Ningbo | Zhejiang | Recruiting |
More Ningbo No. 1 Hospital trials in China
Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population
Recruiting
Optimizing Intervention Effects in Children and Adolescents
Active, not recruiting
Pre-procedural Risk Score-Based Endoscopist Assignment for Pain Reduction in Unsedated Colonoscopy
Starting soon
Healthy Weight Management Project for Overweight and Obesity Children
Active, not recruiting
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06987760 on ClinicalTrials.gov ↗ ← All trials in China